Rybelsus (semaglutide) is a once-daily pill used to help lower blood sugar in adults with type 2 diabetes (T2D).It belongs to a group of medicines called GLP-1 receptor agonists.The FDA has now approved this medicine… Read more
Kygevvi is a new oral medicine for people with thymidine kinase 2 deficiency (TK2d), an extremely rare genetic condition affecting the muscles.The FDA has approved it for the treatment of adults and children with TK2d… Read more
Darzalex Faspro is a medicine used to treat adults with multiple myeloma, a type of blood cancer, and amyloidosis, a rare condition where abnormal proteins build up in organs. It’s also the first treatment approved… Read more
Zepzelca (lurbinectedin) is a chemotherapy medicine that damages the DNA of cancer cells by disrupting their protein function and ability to repair DNA.This action makes it difficult for cancer cells to grow, survive, and spread.Atezolizumab… Read more
Caplyta (lumateperone) is a once-daily oral medicine now approved to be used with antidepressants to treat major depressive disorder (MDD) in adults.It belongs to a group of medicines called atypical antipsychotics.While experts don’t fully understand… Read more
Linzess (linaclotide) is a prescription medicine that helps ease constipation caused by irritable bowel syndrome (IBS-C).It works by drawing more fluid into your intestines, which makes it easier for stool to pass.The FDA has now… Read more
Blenrep (belantamab mafodotin-blmf) is a type of cancer medicine called an antibody-drug conjugate.It works by finding and attaching to a protein called B-cell maturation antigen (BCMA), which is found on multiple myeloma cells.Once inside the… Read more
Revuforj (revumenib) is an oral medicine approved for treating a type of cancer called acute myeloid leukemia (AML) that affects your bone marrow and blood. In 2024, Revuforj became the first approved medicine for treating… Read more
Keytruda Qlex is a new form of pembrolizumab, a cancer-fighting lab-made antibody that helps your immune system find and attack cancer cells.Unlike the original 30-minute intravenous (IV) drip, the Keytruda Qlex shot is a quick… Read more
What Is Besremi, and Why Does It Matter? Besremi (ropeginterferon alfa-2b) is now FDA-approved to treat adults with a rare blood disorder called essential thrombocythemia. Before this approval, this medicine was already available for adults… Read more